Miles Congreve
E474944
Miles Congreve is a pharmaceutical scientist and entrepreneur best known as a co-founder of Heptares Therapeutics, a company specializing in structure-based drug discovery targeting G protein–coupled receptors (GPCRs).
All labels observed (1)
| Label | Occurrences |
|---|---|
| Miles Congreve canonical | 1 |
Statements (26)
| Predicate | Object |
|---|---|
| instanceOf |
company founder
ⓘ
entrepreneur ⓘ pharmaceutical scientist ⓘ |
| associatedWith | Sosei Heptares NERFINISHED ⓘ |
| coFounded | Heptares Therapeutics NERFINISHED ⓘ |
| countryOfActivity | United Kingdom NERFINISHED ⓘ |
| employer | Heptares Therapeutics NERFINISHED ⓘ |
| fieldOfWork |
G protein–coupled receptor biology
ⓘ
drug discovery ⓘ medicinal chemistry ⓘ pharmaceutical sciences ⓘ |
| hasRole |
drug discovery project leader
ⓘ
scientific leader at Heptares Therapeutics ⓘ |
| industry |
biotechnology
ⓘ
pharmaceutical industry ⓘ |
| knownFor |
co-founding Heptares Therapeutics
ⓘ
research on G protein–coupled receptors ⓘ structure-based drug discovery ⓘ |
| notableContribution |
application of structure-based methods to GPCR drug discovery
ⓘ
development of GPCR-targeted therapeutics at Heptares Therapeutics ⓘ |
| specializesIn |
G protein–coupled receptors
NERFINISHED
ⓘ
biologics design ⓘ small-molecule therapeutics ⓘ structure-based drug design ⓘ |
| workFocus |
structure-based design of biologics
ⓘ
structure-based design of small-molecule drugs ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.